Company Directory > CRO > TrialBlaze

TrialBlaze

Wilmington, North Carolina, USA
VISIT WEBSITE
TrialBlaze is a technology-enabled Patient Recruitment Organization (PRO) that specializes in accelerating clinical trial enrollment through data-driven digital marketing and patient advocacy engagement. The company focuses on bridging the gap between clinical trial sites and eligible patient populations, particularly in high-competition therapeutic areas. The platform utilizes a proprietary screening and referral management system to ensure that only high-quality, pre-qualified candidates are sent to investigative sites. By reducing the administrative burden on site staff and improving the patient experience during the initial outreach phase, TrialBlaze aims to shorten drug development timelines for biotech and pharmaceutical sponsors.
CLASSIFICATION
Company Type:CRO
Industry:Digital Health
Sub-Industry:Clinical Trial Recruitment & Patient Engagement
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:Estimated $1M-$3M
Investors:Private Angel Investors, Bootstrapped/Founder-led
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Clinical Trial Services, Patient Recruitment Software
Active Trials:45
Trial Phases:Phase 1: 5 | Phase 2: 15 | Phase 3: 20 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various Site Management Organizations (SMOs), Independent Clinical Research Sites, Patient Advocacy Groups
COMPETITION
Position:Emerging
Competitors:SubjectWell, Antidote.me, StudyKIK, Trialbee, OneStudyTeam (Reify Health)
LEADERSHIP
Key Executives:
Brian Townsend - CEO
Scientific Founders:Brian Townsend
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with TrialBlaze. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.